Lantern Pharma's total assets for Q3 2024 were $30.29M, a decrease of -14.88% from the previous quarter. LTRN total liabilities were $3.70M for the fiscal quarter, a -20.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.